Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study
2021; Lippincott Williams & Wilkins; Volume: 73; Issue: 6 Linguagem: Inglês
10.1002/hep.31797
ISSN1527-3350
AutoresCumali Efe, Renumathy Dhanasekaran, Craig Lammert, Berat Ebik, Fátima Higuera-de la Tijera, Costica Aloman, Ali Rıza Çalışkan, Mirta Peralta, Alessio Gerussi, Hatef Massoumi, Andreea M. Catana, Murat Torğutalp, Tuğrul Pürnak, Cristina Rigamonti, Andrés Gómez-Aldana, Nidah S. Khakoo, Hüseyin Kaçmaz, Leyla Nazal, Shalom Frager, Nurhan Demir, Kader İrak, Zeynep Melekoğlu Ellik, Yasemin Balaban, Kadri Atay, Fatih Eren, Laura Cristoferi, Ersin Batıbay, Álvaro Urzúa, Romée J.A.L.M. Snijders, Murat Kıyıcı, Murat Akyıldız, Nazım Ekin, Rotonya M. Carr, Murat Harputluoğlu, İbrahim Hatemı, Manuel Mendizábal, Marcelo Silva, Ramazan İdilman, Marina G. Silveira, Joost P.H. Drenth, David N. Assis, Einar S. Björnsson, James L. Boyer, Pietro Invernizzi, Cynthia Levy, Thomas D. Schiano, Ezequiel Ridruejo, Staffan Wåhlin,
Tópico(s)Liver Disease and Transplantation
ResumoData regarding outcome of COVID-19 in patients with autoimmune hepatitis (AIH) are lacking.
Referência(s)